291. Hirschsprung disease, entire colon type Clinical trials / Disease details
Clinical trials : 14 / Drugs : 35 - (DrugBank : 15) / Drug target gene : 0 - Drug target pathway : 0
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02343562 (ClinicalTrials.gov) | October 2014 | 9/1/2015 | Probiotics for Prophylaxis of Postoperative Hirschsprungs Associated Enterocolitis | Probiotics for Prophylaxis of Postoperative Hirschsprungs Associated Enterocolitis | Hirschsprung Disease | Dietary Supplement: Probiotics;Dietary Supplement: Placebo | Cairo University | NULL | Unknown status | 6 Months | 12 Years | All | 40 | Phase 4 | Egypt |
2 | NCT02350088 (ClinicalTrials.gov) | January 2014 | 17/1/2015 | Fast-track Surgery in the Treatment of Hirschsprung's Disease | Fast-track Surgery in the Treatment of Hirschsprung's Disease | Surgery | Drug: probiotics;Drug: placebo | Tongji Hospital | Children's Hospital Boston | Recruiting | 1 Year | 18 Years | Both | 100 | N/A | China |
3 | NCT01934959 (ClinicalTrials.gov) | January 2008 | 21/8/2013 | A Trial on Probiotics in Preventing Hirschsprung's Disease Associated Entercolitis | A Prospective Multicenter Randomized Controlled Trial on Probiotics in Preventing Hirschsprung's Disease Associated Entercolitis | Probiotics;Hirschsprung's Disease Associated Enterocolitis | Drug: Bifico | Tongji Hospital | Anhui Provincial Hospital | Completed | 1 Month | 13 Years | Both | 60 | Phase 0 | NULL |